Literature DB >> 30038021

Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis.

Danilo B Medinas1,2,3, Pablo Rozas4,2,3, Francisca Martínez Traub4,2,3, Ute Woehlbier4,3,5, Robert H Brown6, Daryl A Bosco6, Claudio Hetz1,2,3,7,8.   

Abstract

Abnormal modifications to mutant superoxide dismutase 1 (SOD1) are linked to familial amyotrophic lateral sclerosis (fALS). Misfolding of wild-type SOD1 (SOD1WT) is also observed in postmortem tissue of a subset of sporadic ALS (sALS) cases, but cellular and molecular mechanisms generating abnormal SOD1WT species are unknown. We analyzed aberrant human SOD1WT species over the lifetime of transgenic mice and found the accumulation of disulfide-cross-linked high-molecular-weight SOD1WT aggregates during aging. Subcellular fractionation of spinal cord tissue and protein overexpression in NSC-34 motoneuron-like cells revealed that endoplasmic reticulum (ER) localization favors oxidation and disulfide-dependent aggregation of SOD1WT We established a pharmacological paradigm of chronic ER stress in vivo, which recapitulated SOD1WTaggregation in young transgenic mice. These species were soluble in nondenaturing detergents and did not react with a SOD1 conformation-specific antibody. Interestingly, SOD1WT aggregation under ER stress correlated with astrocyte activation in the spinal cord of transgenic mice. Finally, the disulfide-cross-linked SOD1WT species were also found augmented in spinal cord tissue of sALS patients, correlating with the presence of ER stress markers. Overall, this study suggests that ER stress increases the susceptibility of SOD1WT to aggregate during aging, operating as a possible risk factor for developing ALS.

Entities:  

Keywords:  ER stress; aging; amyotrophic lateral sclerosis; protein aggregation; wild-type SOD1

Mesh:

Substances:

Year:  2018        PMID: 30038021      PMCID: PMC6094144          DOI: 10.1073/pnas.1801109115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  BCL-2 family: integrating stress responses at the ER to control cell demise.

Authors:  Philippe Pihán; Amado Carreras-Sureda; Claudio Hetz
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

Review 2.  The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability.

Authors:  Pablo Rozas; Leslie Bargsted; Francisca Martínez; Claudio Hetz; Danilo B Medinas
Journal:  Neurosci Lett       Date:  2016-05-02       Impact factor: 3.046

3.  Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.

Authors:  P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Lindberg; Mikael Oliveberg; Stefan L Marklund
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

4.  Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.

Authors:  D Jaarsma; E D Haasdijk; J A Grashorn; R Hawkins; W van Duijn; H W Verspaget; J London; J C Holstege
Journal:  Neurobiol Dis       Date:  2000-12       Impact factor: 5.996

5.  Tryptophan 32 potentiates aggregation and cytotoxicity of a copper/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis.

Authors:  David M Taylor; Bernard F Gibbs; Edor Kabashi; Sandra Minotti; Heather D Durham; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2007-03-27       Impact factor: 5.157

6.  An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.

Authors:  Stefania Guareschi; Emanuela Cova; Cristina Cereda; Mauro Ceroni; Elena Donetti; Daryl A Bosco; Davide Trotti; Piera Pasinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-13       Impact factor: 11.205

7.  Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.

Authors:  Bradley J Turner; Julie D Atkin; Manal A Farg; Da Wei Zang; Alan Rembach; Elizabeth C Lopes; Justin D Patch; Andrew F Hill; Surindar S Cheema
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

8.  A ditryptophan cross-link is responsible for the covalent dimerization of human superoxide dismutase 1 during its bicarbonate-dependent peroxidase activity.

Authors:  Danilo B Medinas; Fabio C Gozzo; Luiz F A Santos; Amadeu H Iglesias; Ohara Augusto
Journal:  Free Radic Biol Med       Date:  2010-06-30       Impact factor: 7.376

Review 9.  Proteostasis disturbance in amyotrophic lateral sclerosis.

Authors:  Danilo B Medinas; Vicente Valenzuela; Claudio Hetz
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

10.  A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.

Authors:  Smita Saxena; Erik Cabuy; Pico Caroni
Journal:  Nat Neurosci       Date:  2009-03-29       Impact factor: 24.884

View more
  34 in total

1.  Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders.

Authors:  Danilo B Medinas; Younis Hazari; Claudio Hetz
Journal:  Prog Mol Subcell Biol       Date:  2021

2.  MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.

Authors:  Qiang Wang; Dongyu Zhao; Miao Xian; Zhuo Wang; Enguang Bi; Pan Su; Jianfei Qian; Xingzhe Ma; Maojie Yang; Lintao Liu; Youli Zu; Sai Ravi Pingali; Kaifu Chen; Zhen Cai; Qing Yi
Journal:  Blood       Date:  2020-11-26       Impact factor: 22.113

3.  Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis.

Authors:  Danilo Bilches Medinas; Sajid Malik; Esra Yıldız-Bölükbaşı; Janina Borgonovo; Mirva J Saaranen; Hery Urra; Eduardo Pulgar; Muhammad Afzal; Darwin Contreras; Madison T Wright; Felipe Bodaleo; Gabriel Quiroz; Pablo Rozas; Sara Mumtaz; Rodrigo Díaz; Carlos Rozas; Felipe Cabral-Miranda; Ricardo Piña; Vicente Valenzuela; Ozgun Uyan; Christopher Reardon; Ute Woehlbier; Robert H Brown; Miguel Sena-Esteves; Christian Gonzalez-Billault; Bernardo Morales; Lars Plate; Lloyd W Ruddock; Miguel L Concha; Claudio Hetz; Aslıhan Tolun
Journal:  EMBO J       Date:  2021-12-14       Impact factor: 11.598

4.  Oxidation of active cysteines mediates protein aggregation of S10R, the cataract-associated mutant of mouse GammaB-crystallin.

Authors:  Wenjuan Hou; Ajay Pande; Jayanti Pande
Journal:  Proteins       Date:  2022-07-07

Review 5.  Prionoids in amyotrophic lateral sclerosis.

Authors:  Philippe Gosset; William Camu; Cedric Raoul; Alexandre Mezghrani
Journal:  Brain Commun       Date:  2022-06-09

Review 6.  The role of endoplasmic reticulum stress in astrocytes.

Authors:  Savannah G Sims; Rylee N Cisney; Marissa M Lipscomb; Gordon P Meares
Journal:  Glia       Date:  2021-08-31       Impact factor: 8.073

7.  Profiling Cysteine Reactivity and Oxidation in the Endoplasmic Reticulum.

Authors:  Tyler J Bechtel; Chun Li; Eleni A Kisty; Aaron J Maurais; Eranthie Weerapana
Journal:  ACS Chem Biol       Date:  2020-01-15       Impact factor: 5.100

Review 8.  Implication of post-translationally modified SOD1 in pathological aging.

Authors:  Kashfia Shafiq; Nitesh Sanghai; Ying Guo; Jiming Kong
Journal:  Geroscience       Date:  2021-02-19       Impact factor: 7.713

Review 9.  Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.

Authors:  Larissa-Nele Schaffert; Wayne G Carter
Journal:  Brain Sci       Date:  2020-04-11

Review 10.  Interplay Between the Unfolded Protein Response and Immune Function in the Development of Neurodegenerative Diseases.

Authors:  Paulina García-González; Felipe Cabral-Miranda; Claudio Hetz; Fabiola Osorio
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.